豚ワクチン市場：製品タイプ別、対象疾患別-2025-2030年の世界予測

豚ワクチン市場は、2023年に14億7,000万米ドルと評価され、2024年には15億8,000万米ドルに達すると予測され、CAGR 7.54％で成長し、2030年には24億5,000万米ドルになると予測されています。

豚ワクチン市場は、豚の伝染病の予防と制御を目的としたワクチンの生産、流通、適用によって定義され、主に豚の健康を維持し、バイオセキュリティを確保し、持続可能な豚肉生産を支援する必要性に後押しされています。これらのワクチンの用途は、豚繁殖・呼吸器症候群（PRRS）、豚インフルエンザ、マイコプラズマなど様々な疾病に及びます。エンドユーザーは主に動物病院、養豚場、畜産施設などです。主な成長要因としては、豚の病気の発生率の増加、世界の豚肉製品の需要の増加、動物の健康と福祉に関する意識の高まりなどが挙げられます。市場力学はさらに、組換えDNA技術や、サブユニットワクチンやDNAワクチンといった新しいタイプのワクチン開拓といった技術的進歩によって形成されており、特に研究開発や戦略的パートナーシップに投資する企業にとって潜在的なビジネスチャンスとなっています。しかし課題としては、厳しい規制の枠組み、ワクチン開発と生産に関連する高コスト、飼料やその他の家畜必需品の価格変動などがあり、これらは市場拡大の妨げとなる可能性があります。さらに、ワクチン効力のばらつきや新種の病原体の出現による制約にも直面しています。その結果、技術革新が必要な分野には、より幅広い作用スペクトルを持つワクチンの開発、ワクチンの安定性と保存条件の強化、疾病モニタリングとワクチン管理のためのデジタルツールの統合などがあります。こうした機会を活用するために、企業は最先端の研究、世界な流通ネットワーク、規制状況の徹底的な理解への投資を優先すべきです。市場情勢の急速な進展と競合は、新たな科学的知見や消費者ニーズに適応し、動物の健康、持続可能性、経済的存続のバランスを確保するための機敏な戦略を要求しています。

市場力学：急速に進化する豚ワクチン市場の主要市場インサイトを公開

豚ワクチン市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 豚肉消費の増加
  • 家畜の健康に関する意識の高まり
• 市場抑制要因
  • ワクチンの入手可能性の制限
• 市場機会
  • 新規ワクチン開発のための研究開発
• 市場の課題
  • 獣医師の不足

ポーターの5つの力豚ワクチン市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：豚ワクチン市場における外部からの影響の把握

外部マクロ環境要因は、豚ワクチン市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析豚ワクチン市場における競合情勢の把握

豚ワクチン市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス豚ワクチン市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、豚ワクチン市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨豚ワクチン市場における成功への道筋を描く

豚ワクチン市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 豚肉の消費量増加
    • 家畜の健康に関する意識の高まり
  • 抑制要因
    • ワクチンの入手が限られている
  • 機会
    • 新規ワクチン開発のための研究開発
  • 課題
    • 獣医師の不足
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 豚ワクチン市場：製品別

• 弱毒生ワクチン
• DNAワクチン
• 不活化ワクチン
• 組み換えワクチン
• サブユニットワクチン

第7章 豚ワクチン市場：タイプ別

• アクチノバチルス・プレウロニューモニアエ
• 豚コレラ
• 口蹄疫
• M.ヒョウ
• ペドフ
• 豚サーコウイルス2型
• 豚パルボウイルス
• 抗レトロウイルス薬
• 仮性狂犬病
• 豚インフルエンザ

第8章 豚ワクチン市場ターゲット疾患

• 関節炎
• ボルデテラ鼻炎
• 下痢
• 口蹄疫
• 豚サーコウイルス関連疾患
• 豚繁殖呼吸器症候群
• 仮性狂犬病
• 豚インフルエンザ

第9章 南北アメリカの豚ワクチン市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の豚ワクチン市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの豚ワクチン市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Bayer AG
• Ceva Sante Animale
• China, Jinyu Bio-technology Co., Ltd.
• Covetrus Inc.
• Dechra Pharmaceuticals plc
• Elanco Animal Health Incorporated
• HIPRA
• Huvepharma EOOD
• IDEXX Laboratories, Inc.
• Indian Immunologicals Ltd
• Merck & Co., Inc.
• Phibro Animal Health
• Vetoquinol S.A.
• Virbac S.A.
• Zoetis Inc.

LIST OF FIGURES

• FIGURE 1. SWINE VACCINES MARKET RESEARCH PROCESS
• FIGURE 2. SWINE VACCINES MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL SWINE VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL SWINE VACCINES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL SWINE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL SWINE VACCINES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL SWINE VACCINES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL SWINE VACCINES MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL SWINE VACCINES MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS SWINE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS SWINE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES SWINE VACCINES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES SWINE VACCINES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC SWINE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC SWINE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA SWINE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA SWINE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. SWINE VACCINES MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. SWINE VACCINES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. SWINE VACCINES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL SWINE VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL SWINE VACCINES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL SWINE VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. SWINE VACCINES MARKET DYNAMICS
• TABLE 7. GLOBAL SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL SWINE VACCINES MARKET SIZE, BY ATTENUATED LIVE VACCINES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL SWINE VACCINES MARKET SIZE, BY DNA VACCINES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL SWINE VACCINES MARKET SIZE, BY INACTIVATED VACCINES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL SWINE VACCINES MARKET SIZE, BY RECOMBINANT VACCINES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL SWINE VACCINES MARKET SIZE, BY SUBUNIT VACCINES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL SWINE VACCINES MARKET SIZE, BY ACTINOBACILLUS PLEUROPNEUMONIAE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL SWINE VACCINES MARKET SIZE, BY CLASSICAL SWINE FEVER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL SWINE VACCINES MARKET SIZE, BY FOOT & MOUTH DISEASE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL SWINE VACCINES MARKET SIZE, BY M. HYO, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL SWINE VACCINES MARKET SIZE, BY PEDV, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL SWINE VACCINES MARKET SIZE, BY PORCINE CIRCOVIRUS TYPE 2, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL SWINE VACCINES MARKET SIZE, BY PORCINE PARVOVIRUS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL SWINE VACCINES MARKET SIZE, BY PRRS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL SWINE VACCINES MARKET SIZE, BY PSEUDORABIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL SWINE VACCINES MARKET SIZE, BY SWINE INFLUENZA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL SWINE VACCINES MARKET SIZE, BY ARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL SWINE VACCINES MARKET SIZE, BY BORDETELLA RHINITIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL SWINE VACCINES MARKET SIZE, BY DIARRHEA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL SWINE VACCINES MARKET SIZE, BY FOOT & MOUTH DISEASE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL SWINE VACCINES MARKET SIZE, BY PORCINE CIRCOVIRUS ASSOCIATED DISEASE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL SWINE VACCINES MARKET SIZE, BY PORCINE REPRODUCTIVE & RESPIRATORY SYNDROME, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL SWINE VACCINES MARKET SIZE, BY PSEUDORABIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL SWINE VACCINES MARKET SIZE, BY SWINE INFLUENZA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 34. AMERICAS SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 35. AMERICAS SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
• TABLE 36. AMERICAS SWINE VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 37. ARGENTINA SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 38. ARGENTINA SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 39. ARGENTINA SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
• TABLE 40. BRAZIL SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 41. BRAZIL SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 42. BRAZIL SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
• TABLE 43. CANADA SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 44. CANADA SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 45. CANADA SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
• TABLE 46. MEXICO SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 47. MEXICO SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 48. MEXICO SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
• TABLE 49. UNITED STATES SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 50. UNITED STATES SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 51. UNITED STATES SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
• TABLE 52. UNITED STATES SWINE VACCINES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 53. ASIA-PACIFIC SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 54. ASIA-PACIFIC SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 55. ASIA-PACIFIC SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
• TABLE 56. ASIA-PACIFIC SWINE VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 57. AUSTRALIA SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 58. AUSTRALIA SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 59. AUSTRALIA SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
• TABLE 60. CHINA SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 61. CHINA SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 62. CHINA SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
• TABLE 63. INDIA SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 64. INDIA SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 65. INDIA SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
• TABLE 66. INDONESIA SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 67. INDONESIA SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 68. INDONESIA SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
• TABLE 69. JAPAN SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 70. JAPAN SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 71. JAPAN SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
• TABLE 72. MALAYSIA SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 73. MALAYSIA SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 74. MALAYSIA SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
• TABLE 75. PHILIPPINES SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 76. PHILIPPINES SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 77. PHILIPPINES SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
• TABLE 78. SINGAPORE SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 79. SINGAPORE SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 80. SINGAPORE SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
• TABLE 81. SOUTH KOREA SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 82. SOUTH KOREA SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 83. SOUTH KOREA SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
• TABLE 84. TAIWAN SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 85. TAIWAN SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 86. TAIWAN SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
• TABLE 87. THAILAND SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 88. THAILAND SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 89. THAILAND SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
• TABLE 90. VIETNAM SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 91. VIETNAM SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 92. VIETNAM SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
• TABLE 93. EUROPE, MIDDLE EAST & AFRICA SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 94. EUROPE, MIDDLE EAST & AFRICA SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 95. EUROPE, MIDDLE EAST & AFRICA SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
• TABLE 96. EUROPE, MIDDLE EAST & AFRICA SWINE VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 97. DENMARK SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 98. DENMARK SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 99. DENMARK SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
• TABLE 100. EGYPT SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 101. EGYPT SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 102. EGYPT SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
• TABLE 103. FINLAND SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 104. FINLAND SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 105. FINLAND SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
• TABLE 106. FRANCE SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 107. FRANCE SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 108. FRANCE SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
• TABLE 109. GERMANY SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 110. GERMANY SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 111. GERMANY SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
• TABLE 112. ISRAEL SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 113. ISRAEL SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 114. ISRAEL SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
• TABLE 115. ITALY SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 116. ITALY SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 117. ITALY SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
• TABLE 118. NETHERLANDS SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 119. NETHERLANDS SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 120. NETHERLANDS SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
• TABLE 121. NIGERIA SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 122. NIGERIA SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 123. NIGERIA SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
• TABLE 124. NORWAY SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 125. NORWAY SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 126. NORWAY SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
• TABLE 127. POLAND SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 128. POLAND SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 129. POLAND SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
• TABLE 130. QATAR SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 131. QATAR SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 132. QATAR SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
• TABLE 133. RUSSIA SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 134. RUSSIA SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 135. RUSSIA SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
• TABLE 136. SAUDI ARABIA SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 137. SAUDI ARABIA SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 138. SAUDI ARABIA SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
• TABLE 139. SOUTH AFRICA SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 140. SOUTH AFRICA SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 141. SOUTH AFRICA SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
• TABLE 142. SPAIN SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 143. SPAIN SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 144. SPAIN SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
• TABLE 145. SWEDEN SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 146. SWEDEN SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 147. SWEDEN SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
• TABLE 148. SWITZERLAND SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 149. SWITZERLAND SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 150. SWITZERLAND SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
• TABLE 151. TURKEY SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 152. TURKEY SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 153. TURKEY SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
• TABLE 154. UNITED ARAB EMIRATES SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 155. UNITED ARAB EMIRATES SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 156. UNITED ARAB EMIRATES SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
• TABLE 157. UNITED KINGDOM SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 158. UNITED KINGDOM SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 159. UNITED KINGDOM SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
• TABLE 160. SWINE VACCINES MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 161. SWINE VACCINES MARKET, FPNV POSITIONING MATRIX, 2023

The Swine Vaccines Market was valued at USD 1.47 billion in 2023, expected to reach USD 1.58 billion in 2024, and is projected to grow at a CAGR of 7.54%, to USD 2.45 billion by 2030.

The swine vaccines market is defined by the production, distribution, and application of vaccines that aim to prevent and control infectious diseases in pigs, primarily driven by the necessity to maintain swine health, ensure biosecurity, and support sustainable pork production. The application of these vaccines spans across various diseases such as Porcine Reproductive and Respiratory Syndrome (PRRS), Swine Influenza, and Mycoplasma, to name a few. End-users predominantly encompass veterinary clinics, swine farms, and animal husbandry facilities. Key growth factors include the increasing incidence of swine diseases, rising demand for pork products globally, and heightened awareness regarding animal health and welfare. Market dynamics are further shaped by technological advancements such as recombinant DNA technology and the development of newer vaccine types such as subunit and DNA vaccines, presenting potential opportunities particularly for companies investing in R&D and strategic partnerships. However, challenges include stringent regulatory frameworks, high costs associated with vaccine development and production, and the fluctuating prices of feed and other livestock essentials, which can hinder market expansion. Moreover, the industry faces limitations due to varying vaccine efficacy and the emergence of novel pathogens. Consequently, areas ripe for innovation include the development of vaccines with broader spectrums of action, enhancing vaccine stability and storage conditions, and the integration of digital tools for disease monitoring and vaccine management. To capitalize on these opportunities, businesses should prioritize investment in cutting-edge research, global distribution networks, and a thorough understanding of the regulatory landscape. The swine vaccines market is characterized by rapid advancements and a competitive landscape, demanding agile strategies to adapt to new scientific findings and consumer needs, ensuring a robust balance between animal health, sustainability, and economic viability.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Swine Vaccines Market

The Swine Vaccines Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising consumption of pork meat
  • Growing awareness related to livestock health
• Market Restraints
  • Limited availability of vaccine
• Market Opportunities
  • R&D for novel vaccine developments
• Market Challenges
  • Dearth of veterinary practitioners

Porter's Five Forces: A Strategic Tool for Navigating the Swine Vaccines Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Swine Vaccines Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Swine Vaccines Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Swine Vaccines Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Swine Vaccines Market

A detailed market share analysis in the Swine Vaccines Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Swine Vaccines Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Swine Vaccines Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Swine Vaccines Market

A strategic analysis of the Swine Vaccines Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Swine Vaccines Market, highlighting leading vendors and their innovative profiles. These include Bayer AG, Ceva Sante Animale, China, Jinyu Bio-technology Co., Ltd., Covetrus Inc., Dechra Pharmaceuticals plc, Elanco Animal Health Incorporated, HIPRA, Huvepharma EOOD, IDEXX Laboratories, Inc., Indian Immunologicals Ltd, Merck & Co., Inc., Phibro Animal Health, Vetoquinol S.A., Virbac S.A., and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Swine Vaccines Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Attenuated Live Vaccines, DNA Vaccines, Inactivated Vaccines, Recombinant Vaccines, and Subunit Vaccines.
• Based on Type, market is studied across Actinobacillus Pleuropneumoniae, Classical Swine Fever, Foot & Mouth Disease, M. Hyo, PEDV, Porcine Circovirus Type 2, Porcine Parvovirus, PRRS, Pseudorabies, and Swine Influenza.
• Based on Target Disease, market is studied across Arthritis, Bordetella Rhinitis, Diarrhea, Foot & Mouth Disease, Porcine Circovirus Associated Disease, Porcine Reproductive & Respiratory Syndrome, Pseudorabies, and Swine Influenza.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising consumption of pork meat
    • 5.1.1.2. Growing awareness related to livestock health
  • 5.1.2. Restraints
    • 5.1.2.1. Limited availability of vaccine
  • 5.1.3. Opportunities
    • 5.1.3.1. R&D for novel vaccine developments
  • 5.1.4. Challenges
    • 5.1.4.1. Dearth of veterinary practitioners
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Swine Vaccines Market, by Product

• 6.1. Introduction
• 6.2. Attenuated Live Vaccines
• 6.3. DNA Vaccines
• 6.4. Inactivated Vaccines
• 6.5. Recombinant Vaccines
• 6.6. Subunit Vaccines

7. Swine Vaccines Market, by Type

• 7.1. Introduction
• 7.2. Actinobacillus Pleuropneumoniae
• 7.3. Classical Swine Fever
• 7.4. Foot & Mouth Disease
• 7.5. M. Hyo
• 7.6. PEDV
• 7.7. Porcine Circovirus Type 2
• 7.8. Porcine Parvovirus
• 7.9. PRRS
• 7.10. Pseudorabies
• 7.11. Swine Influenza

8. Swine Vaccines Market, by Target Disease

• 8.1. Introduction
• 8.2. Arthritis
• 8.3. Bordetella Rhinitis
• 8.4. Diarrhea
• 8.5. Foot & Mouth Disease
• 8.6. Porcine Circovirus Associated Disease
• 8.7. Porcine Reproductive & Respiratory Syndrome
• 8.8. Pseudorabies
• 8.9. Swine Influenza

9. Americas Swine Vaccines Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Swine Vaccines Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Swine Vaccines Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Bayer AG
• 2. Ceva Sante Animale
• 3. China, Jinyu Bio-technology Co., Ltd.
• 4. Covetrus Inc.
• 5. Dechra Pharmaceuticals plc
• 6. Elanco Animal Health Incorporated
• 7. HIPRA
• 8. Huvepharma EOOD
• 9. IDEXX Laboratories, Inc.
• 10. Indian Immunologicals Ltd
• 11. Merck & Co., Inc.
• 12. Phibro Animal Health
• 13. Vetoquinol S.A.
• 14. Virbac S.A.
• 15. Zoetis Inc.